LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

LLY

745.48

-1.34%↓

JNJ

153.61

+0.7%↑

UNH

321.58

+1.9%↑

ABBV

184.82

-0.47%↓

NVO

68.12

+1.76%↑

Search

Exact Sciences Corp

Closed

SectorHealthcare

57.82 1.67

Overview

Share price change

24h

Current

Min

56.15

Max

57.87

Key metrics

By Trading Economics

Income

763M

-101M

Sales

-6.6M

707M

EPS

-0.358

Profit margin

-14.32

Employees

6,900

EBITDA

719M

-96M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+22.32% upside

Dividends

By Dow Jones

Next Earnings

30 Jul 2025

Market Stats

By TradingEconomics

Market Cap

707M

10B

Previous open

56.15

Previous close

57.82

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Exact Sciences Corp Chart

Past performance is not a reliable indicator of future results.

Related News

6 Nov 2024, 10:24 UTC

Earnings

These Stocks Are Moving the Most Today: Trump Media, Tesla, First Solar, Coinbase, Super Micro, Nvidia, Exact Sciences, and More -- Barrons.com

Peer Comparison

Price change

Exact Sciences Corp Forecast

Price Target

By TipRanks

22.32% upside

12 Months Forecast

Average 69.65 USD  22.32%

High 90 USD

Low 54 USD

Based on 19 Wall Street analysts offering 12 month price targets forExact Sciences Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

18

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

45.6 / 54.37Support & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Exact Sciences Corp

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.